Nancy A. Melville October 24, 2022 MONTREAL— Patients who discontinue levothyroxine for subclinical hypothyroidism may gravitate towards becoming mildly hypothyroid again, but they importantly show no differences in terms of symptoms and quality of life — and sometimes show even improvement — compared with those who continue treatment, new research shows. “Our results show feasibility of patient enrollment...